Soliqua
Manufacturing · United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.soliqua100-33.comRevenue
$33.8 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Soliqua
SOLIQUA 100/33 is a once-daily injectable prescription medication that combines the long-acting insulin analog insulin glargine and the GLP-1 receptor agonist lixisenatide. Used alongside diet and exercise in adults with type 2 diabetes mellitus, it targets multiple pathways to help improve blood sugar control when other therapies have not achieved desired results.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Soliqua your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Soliqua, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Soliqua launches new products
Check out if Soliqua is spiking on competitors!
Earning: See what the market has to say on Soliqua recently announced quarterly report
Check if Soliqua has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Soliqua
Click to see if Soliqua had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Soliqua has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Soliqua
Find 2 more new buyers
Compare Similar Companies to Soliqua
Compare insights from companies similar to Soliqua, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Company Profile Activity
Activity Insights
Soliqua is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Soliqua is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Soliqua.
Soliqua Tech Stack
A closer look at the technologies used by Soliqua
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Soliqua
Sign Up For FreeTo access detailed company insights
SOLIQUA 100/33 is a once-daily injectable prescription medication that combines the long-acting insulin analog insulin glargine and the GLP-1 receptor agonist lixisenatide. Used alongside diet and exercise in adults with type 2 diabetes mellitus, it targets multiple pathways to help improve blood sugar control when other therapies have not achieved... Read More
